Stay updated on Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial
Sign up to get notified when there's something new on the Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial page.

Latest updates to the Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial page
- Check4 days agoChange DetectedUI/layout adjustments and content reflow are observed, with no changes to core study data such as outcomes, enrollment, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedUpdated release notes to v3.2.0 with a prominent funding/operating-status notice; previous v3.1.0 version removed. Core page impact includes status updates and potential data/transaction limitations.SummaryDifference3%

- Check40 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2 and the Back to Top element was removed; no core content, pricing, stock, or time-slot data appears affected.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has been updated to reflect a new facility name and location details, including a total of 90 study locations, while some previous locations have been removed. Additionally, there are new publications listed related to the study.SummaryDifference19%

Stay in the know with updates to Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous Sulbactam-ETX2514 for Acinetobacter Infections Clinical Trial page.